Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynecology
Reference9 articles.
1. Brosche T, Kuhn A, Lobodasch K, Sokol ER. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 2021;40:502–8. https://doi.org/10.1002/nau.24589.
2. Zheng Y, Rovner E. Update on urethral bulking for stress urinary incontinence in women. Curr Urol Rep. 2022;23(10):203–9. https://doi.org/10.1007/s11934-022-01099-5.
3. Hoe V, Haller B, Yao HH, O’Connell HE. Urethral bulking agents for the treatment of stress urinary incontinence in women: a systematic review. Neurourol Urodyn. 2021;40:1349–88. https://doi.org/10.1002/nau.24696.
4. Braga A, Caccia G, Papadia A, et al. Urethral bulking agents for the treatment of recurrent stress urinary incontinence: a systematic review and meta-analysis. Maturitas. 2022;163:28–37. https://doi.org/10.1016/j.maturitas.2022.05.007.
5. Kobashi K, Albo M, Dmochowski R, et al. American Urological Association stress-urinary-incontinence guideline. 2017. https://www.auanet.org/guidelines-and-quality/guidelines/stress-urinary-incontinence-(sui)-guideline. Accessed 30 Mar 2023.